India Digest: Fortis, Dr Lal PathLabs, Piramal Enterprises in M&A news

Photo: Reuters

In the latest M&A development, Fortis Healthcare has scrapped a plan to sell its stake in Singapore-listed RHT Health Trust. In other news, Dr Lal PathLabs said its board has approved the acquisition of a 70 per cent stake in a new company while Piramal Enterprises has sold its entire 9.96 per cent stake in Shriram Transport Finance Company.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe

Contact us for corporate subscriptions at subs@dealstreetasia.com.